Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Impetigo Market Size Changed, over the years?
In the past few years, the impetigo market has seen robust growth. The market, projected to rise from $2.25 billion in 2024 to $2.41 billion in 2025, is expected to register a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historic period is attributed to the increasing incidence of skin infections, enhancements in healthcare infrastructure, wider access to telemedicine, increased public funding for infectious diseases, and a surge in demand for topical treatments.
How Much Will the Impetigo Market Be Worth in 2029?
The market size of impetigo is expected to witness considerable growth in the coming years, reaching $3.11 billion by the year 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth projected for this period can be linked to the surge in telemedicine and E-pharmacy, initiatives taken by both government and private sector, an increase in skin infection cases, growth in pediatric population, and increased demand for dermatology clinics. The projected trends for this period include progress in topical treatments, the launch of new antimicrobial agents, zestful collaborations and partnerships, regulatory accreditations, and advancements in existing pipelines.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21209&type=smp
Which is the Largest Company in the Impetigo Market?
Major companies operating in the impetigo market are Roche Holding AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Galderma SA, Shionogi & Co. Ltd., Dr. Reddy’s Laboratories Ltd., Leo Pharma A/S, Torrent Pharmaceuticals Ltd., Almirall S.A, Taro Pharmaceutical Industries Ltd., BioCryst Pharmaceuticals Inc., Melinta Therapeutics Inc., Cutanea Life Sciences Inc., InfectoPharm Arzneimittel und Consilium GmbH, Medimetriks Pharmaceuticals Inc., NovaBay Pharmaceuticals Inc., Ferrer Internacional S.A
What Are the Main Market Drivers in the Impetigo Industry?
The prevalence of skin infections, which entail harmful organisms like bacteria, viruses, fungi, and parasites invading the skin, is increasing. This is expected to boost the impetigo market’s growth. The rise in skin infections can be attributed to factors such as antibiotic resistance, poor sanitation, climate change, weak immune systems, and increased international travel. Treating impetigo involves handling and resolving the infection by focusing on the bacterial pathogens, typically Streptococcus or Staphylococcus species. This can be achieved using topical or oral antibiotics, which alleviate symptoms like itching and discomfort, prevent the infection from spreading, and speed up the healing process while minimizing the chances of complications. A case in point is the September 2024 report by GOV.UK which shows that 13,912 cases of Staphylococcus aureus bacteremia were reported in the financial year of 2022-2023, representing a 7.2% increase from the previous financial year of 2021-2022. The growing rate of skin infections is hence bolstering the impetigo market. Progress in health care faculties is projected to drive the growth of the impetigo market. These establishments, which include hospitals, clinics, and diagnostic centers, offer medical support to patients. The improvement of these facilities is resulting from various factors such as increased healthcare infrastructure investment, a patient-centered care emphasis, population, and aging growth. Enhancing facilities can help manage and treat impetigo by increasing access to specialized dermatological care, making more effective treatment options available, promoting better hygiene practices to prevent infection spread, and facilitating early diagnosis and intervention. This ultimately contributes to better patient outcomes and a reduction in skin infection burden. A report by the American Health Care Association in May 2023 stated that the United States had 6,129 hospitals, a 0.591% increase from the previous year with 6,093 hospitals. Therefore, improvements in healthcare facilities are driving impetigo market growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21209&type=smp
How Is the Impetigo Market Segments Structured?
The impetigo market covered in this report is segmented –
1) By Treatment Type: Topical Antibiotics, Oral Antibiotics, Antiseptic Soaks
2) By Causative Pathogen: Staphylococcus aureus, Streptococcus pyogenes, Other Bacteria
3) By Severity: Mild, Moderate, Severe
4) By Patient Age: Children, Adults, Elderly
Subsegments:
1) By Topical Antibiotics: Mupirocin, Retapamulin, Fusidic Acid
2) By Oral Antibiotics: Cephalexin, Dicloxacillin, Clindamycin
3) By Antiseptic Soaks: Chlorhexidine, Hydrogen Peroxide, Potassium Permanganate
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/impetigo-global-market-report
Which Global Regions Offer the Highest Growth in the Impetigo Market?
North America was the largest region in the impetigo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the impetigo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21209
This Report Delivers Insight On:
1. How big is the impetigo market, and how is it changing globally?
2. Who are the major companies in the impetigo market, and how are they performing?
3. What are the key opportunities and risks in the impetigo market right now?
4. Which products or customer segments are growing the most in the impetigo market?
5. What factors are helping or slowing down the growth of the impetigo market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model